Telomir Pharmaceuticals, Inc. Share Price & Technical Analysis
TELO · $1.29 (0.00%)
Healthcare / Biotechnology
$1.29
0.00%
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macul…
Price chart
Seasonality
May has 0 positive and 3 negative years (last 3 years shown)
-7% return in May, -17% avg return in past 3 year May month.
6% return in 2026, -50% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -21% | 18% | 8% | 8% | -7% | – | – | – | – | – | – | – | 6% |
| 25 | 20% | -17% | -20% | -24% | -27% | -40% | 46% | -32% | 8% | 14% | -13% | 0% | -85% |
| 24 | – | 30% | -42% | 22% | -8% | -23% | -23% | 44% | 21% | -37% | -2% | 3% | -15% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$85.96M
P/E ratio
—
52W high
$3.10
52W low
$1.05
Volume
75,875
Beta
-0.21
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Telomir Pharmaceuticals, Inc. share price today?
- Telomir Pharmaceuticals, Inc. (TELO) last traded around $1.29 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TELO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TELO. Download the app for real-time alerts.
- How can I analyze Telomir Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.